 Simvastatin is a drug that is approved by the Food and Drug Administration FDA to treat high cholesterol. Laboratory research has shown that simvastatin together with dual HER2-targeted therapy slows the growth of breast cancer tumors that had been growing on dual HER2-targeting therapy alone. 